Phase 2 Plasmacytoma Clinical Trials
4 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–4 of 4 trials
Recruiting
Phase 1Phase 2
Frontline Combination CAR-T Cell Therapy for Multiple Myeloma or Plasmacytoma
Multiple MyelomaPlasmacytoma
Shenzhen Geno-Immune Medical Institute20 enrolled2 locationsNCT06429150
Recruiting
Phase 2
Radiation Combined With BCMA/CD3 Bispecific Antibody Therapy for Solitary Bone Plasmacytoma With Mild Bone Marrow Infiltration
Plasma Cell DisordersSolitary Bone PlasmacytomaPlasmacytoma of Bone
Institute of Hematology & Blood Diseases Hospital, China21 enrolled1 locationNCT07115667
Recruiting
Phase 2
SBRT Plus Lenalidomide for Solitary Plasmacytoma: Phase II Trial
Solitary Plasmacytoma
Second Affiliated Hospital, School of Medicine, Zhejiang University41 enrolled1 locationNCT06863584
Recruiting
Phase 2
Chemotherapy Combined With Radiotherapy Versus Radiotherapy Alone for Solitary Plasmacytoma
Solitary Plasmacytoma
Peking Union Medical College Hospital220 enrolled1 locationNCT05248633